Pulmonary arterial hypertension trials in Singapore

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  Where

  Singapore

  Age

  18 years to 75 years

  People

  330 worldwide

  Run by

  Gossamer Bio USA, Inc.

  See details and how to joinNCT06274801 · EU 2023-506334-75-00
• Phase 3Enrolling by invitation
  A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

  Where

  Singapore

  Age

  18 years and over

  People

  1,000 worldwide

  Run by

  United Therapeutics

  See details and how to joinNCT03683186 · EU 2023-509305-68-00
• Phase 3Taking people
  Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

  Where

  Singapore

  Age

  21 years and over

  People

  150 worldwide

  Run by

  National University Hospital, Singapore

  See details and how to joinNCT05473520